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Asthma Management Programs in
Managed Care Organizations
CHRISTINE W. HARTMANN, M.S.S., Ph.D., VITTORIO MAIO, Pharm.D., M.S.,
NEIL I. GOLDFARB, NICOLE COBB, M.A.O.M., and DAVID B. NASH, M.D., M.B.A.

ABSTRACT
The aim of this work was to investigate how managed care organizations (MCOs) currently
approach asthma treatment and management and to determine factors affecting asthma outcomes. A Web-based survey was administered to a national sample of 351 medical directors
of MCOs to investigate the asthma management program components in their organizations
as well as gaps and barriers in the management of patients with asthma. All 134 (38.2%) responding medical directors reported that their organizations monitor asthma patients. Plans
use a variety of asthma management activities, including general member education (90%),
member education by mail (87%), self-management education (85%), and provider education
(82%). Educational resources (89%) and telephone advice nurse (77%) were the most common
self-management strategies offered. Among factors impeding the provision of effective
asthma care, noncompliance with asthma treatment, the inappropriate use of medications, and
the need for multiple medications were cited by virtually all respondents. Health plans rely
on an array of strategies to manage asthma patients. Education encouraging patient self-management is a key component of asthma management programs. However, a considerable number of treatment approach barriers are impeding the achievement of proper asthma care. Without innovative approaches to care, it appears that current MCOs’ asthma management efforts
may not result in substantial improvements in asthma outcomes. (Disease Management
2005;8:339-345)

INTRODUCTION

W

in prevalence,
morbidity, and mortality over the last
decades, asthma is one of the most prominent
and costly public health challenges in children
and adults.1–3 Currently, asthma affects approximately 15 million individuals in the
United States. On an annual basis, 5,000 deaths,
500,000 hospitalizations, and 2 million emergency department visits are attributed to
ITH ITS GENERAL INCREASE

asthma.4–6 In addition, asthma accounts for 14
million school absence days and 14.5 million
work absence days annually.4 Accordingly, the
economic impact for society is astonishing: direct and indirect health care costs for asthma
were estimated to be $12.7 billion in 1998.1,6,7
According to the National Heart, Lung, and
Blood Institute’s (NHLBI) current guidelines,
asthma treatment entails a multilevel intervention including appropriate pharmacological
therapy, patient education, control of asthma
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triggers, and monitoring of asthma severity with
objective measures of lung function.1 The literature reports, however, that compliance with
guidelines falls short.8–10 Suboptimal use of effective medications, gaps in communication between patients and physicians, and inadequate
patient disease self-management are among the
most important reasons for this failure.11
With the objectives of optimizing the process
of care provided to patients and enhancing
healthcare outcomes, disease management (DM)
programs for asthma have become a priority for
managed care organizations (MCOs). For almost
a decade, encouraged by a number of successful
programs showing improvements in terms of
both clinical and humanistic outcomes,12–17
asthma DM programs have been flourishing
across the country. One survey of members of
America’s Health Insurance Plans (formerly the
American Association of Health Plans) reported
that over three quarters of plans surveyed had
an asthma DM program in place in 2000.18 However, there is limited information on how such
programs are structured. The purpose of this survey was to determine how MCOs currently approach asthma treatment and management, and
to identify their biggest challenges and opportunities in improving asthma outcomes.

plaining the survey and asking for their participation in the survey. A link to the online survey instrument was provided in the letter. Potential participants were assured of the
confidentiality of the information collected. A
financial incentive of $50 upon completion of
the questionnaire also was offered.
Data collection
A survey questionnaire was developed by the
project team and mounted on the online survey
portal www.SurveyMonkey.com. The instrument contained questions regarding descriptive
plan information, asthma management program components, and gaps and barriers in the
management of patients with asthma. All survey instruments and procedures were reviewed
and approved by the Thomas Jefferson University Institutional Review Board.
Responses were tracked through the survey
portal. Three follow-up emailings were sent
in 1-week intervals to non-respondents, and
those who requested a printed copy of the
survey were sent one. Two weeks after the
final follow-up mailing, phone calls were
placed to a random sample of 20 non-respondents to determine whether making direct phone calls would further elevate response rates. This attempt was unsuccessful:

METHODS
A Web-based survey was conducted in April
and May of 2004. The target population of the
survey consisted of all medical directors of MCOs
in the United States. The sample list was obtained
from InterStudy Publication’s Competitive Edge
Part I & II (version 13.2), which provided 455
medical directors’ names and addresses, listed as
of January 1, 2003 (the most recent available listing at the time the study was initiated). Duplicate
names were removed. The list was subsequently
cross-tabulated with the Department of Health
Policy’s database of managed care medical directors to determine email addresses and direct
telephone numbers. Efforts were made to obtain
accurate e-mail addresses and phone numbers of
all medical directors listed.
The final sample consisted of 351 medical directors. A letter of invitation was e-mailed to
all potential respondents in the cleaned list, ex-

TABLE 1. CHARACTERISTICS OF MANAGED
CARE ORGANIZATIONS (n  134)
Enrollment size
by book of businessc
None
1–50,000
50,001–100,000
100,001–500,000
 500,000
Region
Nationald
Midwest
Northeast
South
West
aTotals

n (%) a,b
Commercial
23
28
21
35
25

(17)
(21)
(16)
(27)
(19)

Medicaid
52
41
19
16
4

(40)
(31)
(14)
(12)
(3)

18
38
25
30
22

(14)
(29)
(19)
(23)
(17)

Medicare
75
39
8
6
4

(57)
(30)
(6)
(5)
(3)

may not sum 100% due to rounding.
available for all respondents.
c Multiple-response question.
dCharacterized as those MCOs reporting membership in at least two regions.
bNot
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TABLE 2.

METHODS OF IDENTIFYING PATIENTS
ASTHMA (n  134)

WITH

Measurement

n (%)a,b

Claims or encounter date (e.g., CPT-4,
ICD-9 codes)

129 (97)

Pharmacy utilization data (e.g., NDC
codes)

129 (97)

Care manager referral

100 (75)

Physician referral

91 (68)

Self-referral

77 (58)

HEDIS

73 (55)

Predictive modeling software

41 (31)

Member interview or self-assessment

41 (31)

Other

5 (4)

We do not identify patients with asthma

2 (2)

aMultiple-response
bAvailable

question.
for 133 respondents.

only one director out of the 20 completed the
survey online. The survey was officially closed
2 weeks after the final follow-up mailing.
All responses were entered into the form on
the survey Web site, either by the respondents
themselves or, for respondents who completed
the printed instrument, by a survey staff member. The complete data file was subsequently
downloaded in the form of an Excel spreadsheet (Microsoft Corp, Redmond, WA).
Statistical analysis
Data were analyzed using SAS (SAS Institute, version 8.2, Cary, NC). Descriptive statistics were calculated for all variables.
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some commercial members, 60% had some
Medicaid members, and 43% had some
Medicare members. Responses were well-distributed around the country, with a slight majority coming from either the Midwest (29%) or
the South (23%).
Methods used by the responding MCOs to
identify patients with asthma are described in
Table 2. Information collected through this
multiple-response question indicates that almost all responding organizations used claims
or encounter data such as CPT-4 or ICD-9 codes
(97%) and pharmacy utilization data such as
NDC codes (97%) to identify patients. More
than half of these organizations also used care
manager referrals (75%), physician referrals
(68%), self-referral (58%), or the Health Plan
Employer Data and Information Set (HEDIS)
measures (55%). Only two organizations did
not identify asthma patients at all.
With regard to asthma management activities conducted by responding organizations,
there was a large gap between activities pursued by most organizations and those pursued
only by some (Table 3). The most popular activities were general member education (90%),
member education by mail (87%), self-management education (85%), and provider education (82%). Internet member education was
pursued by roughly half of the organizations,
while member incentives to encourage compliance and pharmacy benefit were pursued by
only 11% and 10%, respectively.

TABLE 3.

ASTHMA MANAGEMENT ACTIVITIES (n  134)

Component

n (%)a,b

RESULTS

General member education

118 (90)

Member education by mail

114 (87)

In all, 134 medical directors completed the
online survey, either online (n  132) or in writing (n  2), and 34 declined to participate. The
final response rate was 38.2%, based on 134 responses out of a sample of 351. The completion
rate was 42.3%, based on 134 responses out of
the sample of 317 directors who did not decline.
Respondents were asked to identify basic demographic characteristics of their organizations (Table 1). Most of the plans (83%) had

Self-management education

111 (85)

Provider education

108 (82)

Internet member education

64 (49)

Information Technology member support

31 (24)

Member incentives to encourage compliance

15 (11)

Pharmacy benefit, e.g., waiver of copays

13 (10)

Other management strategy

19 (15)

aMultiple-response
bAvailable

question.
for 131 respondents.
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TABLE 4.

MEMBER SELF-MANAGEMENT STRATEGIES
OFFERED (n  134)

Component

n (%)a,b

Educational resources

119 (89)

Telephone advice nurse

102 (77)

Self-assessment of peak flow

79 (59)

Behavior modification programs

77 (58)

Home visits (assessment of environmental
triggers)

46 (35)

Member/dependent skills training

46 (35)

Other self-management strategies

6 (5)

No self-management strategies

6 (5)

aMultiple-response
bAvailable

question.
for 133 respondents.

As evidenced by the data in Table 3, asthma
self-management strategies comprised part of
most organizations’ asthma management activities. The specific types of self-management
strategies offered are detailed in Table 4. Only
5% of the organizations reported using no selfmanagement strategies. Educational resources
were most frequently employed (89%), with
telephone advice nurse services also being used
by over three quarters of responding organizations. Almost 60% of the organizations also
made use of self-assessment of peak flow and
behavior modification programs.
Organizations also were asked about the
ways in which they assessed the effectiveness
of the management of members with asthma
(Table 5). There was a large variation in the
types of measures used. Most plans were examining emergency room (95%) and inpatient
hospital (91%) service utilization. Other frequently used measures included pharmacy
cost utilization (80%) and quality measures
such as HEDIS and Foundation for Accountability (FACCT; 78%). Organizations also
were interested in oral steroid use (60%). All
other methods, including member satisfaction, return on investment, clinical outcome
measures, and days missed from work or
school were used by fewer than half the organizations.
Respondents were asked to rate on a threeitem scale (not at all, somewhat, and extensively) the extent to which certain factors im-

peded the provision of effective asthma care
from the perspective of the MCO (Table 6).
Based on a total percentage combination of the
somewhat and extensively categories, noncompliance with asthma treatment and inappropriate use of medications were cited as impeding factors by 99% (all but one respondent)
and 97% (all but four respondents), respectively. Other frequently cited impeding factors
include the need for taking multiple medications (96%), the variability of the disease within
an individual (95%), patient psychosocial issues (94%), and lack of provider awareness of
the NHLBI guidelines for asthma (83%).
In a related question, respondents were asked
to rate, using a three-item scale (does not, somewhat, and significantly), the factors that affect
member compliance with the prescribed treatment regimen (Table 7). Patient misunderstanding of the role of prescribed medications in managing asthma was rated as significantly affecting
compliance by 79% of the respondents, while
lack of basic knowledge about asthma as a disease and lack of understanding of specific personal asthma triggers were cited as significant

TABLE 5. METHODS OF ASSESSING THE EFFECTIVENESS
OF MANAGING MEMBERS WITH ASTHMA (n  134)
Measurement

n (%)a,b

Emergency room utilization

124 (95)

Inpatient utilization

118 (91)

Pharmacy costs/utilization

104 (80)

Quality measures (eg, HEDIS, FACCT)

101 (78)

Oral steroid use

78 (60)

Member satisfaction

55 (42)

Specialist utilization

41 (32)

Return on investment

38 (29)

Clinical outcome measures (eg, peak flow)

34 (26)

Functional status assessment

33 (25)

Lost work days

22 (17)

Lost school days

21 (16)

Provider satisfaction

19 (15)

Employer satisfaction

8 (6)

Member longevity program

8 (6)

Other

3 (2)

aMultiple-response
bAvailable

question.
for 130 respondents.
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TABLE 6.

FACTORS IMPEDING ACHIEVEMENT

OF

EFFECTIVE ASTHMA CARE (n  134)
n (%)a,b

Factor

Not at all

Somewhat

Extensively

1 (1)

63 (48)

68 (52)

4 (3)

80 (60)

49 (37)

7 (5)

86 (65)

40 (30)

5 (4)

88 (67)

39 (30)

8 (6)

86 (67)

35 (27)

Lack of provider awareness of the NHLBI Guidelines for
Asthmad

22 (17)

86 (65)

25 (19)

Resource limitations (financial and non-financial)d

24 (18)

85 (64)

24 (18)

Member literacy leveld

18 (14)

96 (72)

19 (14)

32 (24)

81 (61)

19 (14)

60 (45)

56 (42)

17 (13)

14 (11)

103 (77)

16 (12)

19 (14)

103 (78)

10 (8)

54 (41)

72 (54)

7 (5)

87 (66)

40 (30)

5 (4)

Member noncompliance with asthma treatmentc
Member inappropriate use of

medicationsd

Variability of the disease within an individuald
Member need to take multiple

medicationsc

Member psychosocial issuese

patientsc

Inability of providers to follow up with

Cost of the program for member, for asthma-related servicesd
Individual member response to asthma

medicationsd

Multicultural issuesc
Information technology

limitationsd

Plan inability to identify members with asthmac
aMultiple-response

question.
may not sum 100% due to rounding.
cAvailable for 132 respondents.
dAvailable for 133 respondents.
eAvailable for 129 respondents.
bTotals

factors by 73% and 68%, respectively. Overall,
medication safety or concerns about side effects
ranked lowest, with 19% of respondents indicating that it was not an issue, and 71% indicating
it was somewhat an issue.

TABLE 7.

FACTORS AFFECTING COMPLIANCE

Respondents were asked to outline their beliefs regarding members’ use of asthma medications (Table 8). To this single-response question, only 5% of respondents indicated that
they believed members used medications as

WITH

PRESCRIBED TREATMENT REGIMEN (N  134)
n (%)a

Factor

Does not

Somewhat

Significantly

Misunderstanding the role of prescribed medications in
managing his/her asthmab,d

0

28 (21)

103 (79)

Lack of basic knowledge of asthma as a disease c,d

2 (2)

34 (26)

96 (73)

Lack of understanding of his/her specific asthma triggers b,d

1 (1)

41 (31)

89 (68)

0

69 (53)

62 (47)

8 (6)

68 (51)

57 (43)

24 (19)

91 (71)

14 (11)

Need to use multiple

medicationsb,d

Cost/financial concernsc
Medication safety/side effect
aTotals

concerns c,e

may not sum 100% due to rounding.
for 132 respondents.
cAvailable for 133 respondents.
dOne respondent marked “not sure” category (not included in table analyses).
eFour respondents marked “not sure” category (not included in table analyses).
bAvailable
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TABLE 8.

ASTHMA MEDICATIONS USED
MEMBERS (n  134)a

BY

n (%)
Overutilization of “rescue” medications
and underutilization of “control”
medications

86 (65)

Underutilization of “control” medications

26 (20)

Overutilization of “rescue” medications

7 (5)

Use of medications as prescribed

7 (5)

Do not know

4 (3)

Other

3 (2)

aAvailable

for 133 respondents.

prescribed. The majority of respondents (65%)
believed that members overutilized “rescue”
medications and underutilized “control” medications. Regarding underutilization alone,
20% believed this to be the case, and 5% believed that members overutilized “rescue”
medications.
DISCUSSION
This national survey of managed care medical directors provides evidence that asthma is
widely recognized as an important target for
disease (and cost) management efforts. Responding managed care medical directors recognized that education encouraging patient
self-management is needed in order to overcome barriers to achieving asthma care goals
due to member noncompliance and inappropriate use of medications. They indicated that
these barriers are compounded by the complexity of pharmacotherapy, reliance on multiple medications, and attempts to address variability of disease across individual patients.
The majority of respondents believed that patients are not receiving medication therapy
consistent with NHLBI guidelines but instead
are over-reliant on rescue therapies and underadherent to control medication. Paradoxically,
despite these recognized challenges, most responding plans had traditional patient and
provider education programs in place, and
fewer plans were engaged in more innovative
strategies, such as those employing technology
or financial incentives, to influence behavior.

Based on the data collected, the evaluation of
the effectiveness of asthma management strategies also relied more heavily on traditional measures of service utilization and cost, rather than
on clinical and humanistic outcomes. Only 26%
of respondents were measuring clinical outcomes such as peak flows, and 17% of plans reported measuring lost productivity. The survey
results provide some confirmation that, while
plans are concerned with providing high quality, the metrics used to evaluate programs still
are largely focused on costs.
Subgroup analyses did not reveal any major
differences in barriers to management or
management approaches across regions, or by
panel size or type (commercial, Medicaid, or
Medicare), demonstrating that the managed
care community faces common challenges
to management of asthma. Therefore, plans
which are experimenting with new and innovative approaches to management are encouraged to evaluate their efforts using a variety of
relevant metrics and to share these findings
with the broader managed care community.
The largest limitation to interpreting results
from a survey research project often is the potential for response bias (ie, respondents differed systematically from nonrespondents). In
this survey of the most senior medical directors
in a 100% sample of health plans, a 38% response rate was achieved. It is possible that
nonresponders were more likely to be those
plans which are not actively involved in
asthma management, and although the descriptive statistics in Table 1 suggest that the
sample was representative with regard to demographic characteristics, results should be generalized with caution. An additional potential
for bias arises from the survey being targeted
to medical directors, who may tend to explain
gaps in care in a similar fashion across many
disease states. Furthermore, the survey consisted of close-ended items and may not have
adequately captured the depth or variation in
participants’ experiences.
CONCLUSION
This national survey of managed care medical directors supports the position that asthma

ASTHMA MANAGEMENT PROGRAMS IN MANAGED CARE ORGANIZATIONS

management is receiving attention from nearly
all managed care plans. Education, particularly
regarding self-management, appears to be an
essential part of most plans’ approaches to disease and cost management. However, given the
inherent complexity in administering current
pharmacotherapies, these existing educational
efforts alone may not be enough to improve
outcomes significantly. In the future, the availability of simplified therapeutic options may
help, and overall, more innovative, multidimensional approaches should be developed
and evaluated using a variety of metrics.
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